SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-187831
Filing Date
2020-07-06
Accepted
2020-07-06 16:06:59
Documents
2
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV2014 LLCMPM BIOVENTURES 2014 (B), L.P.MPM BIOVENTURES 2014 GP LLCMPM BIOVENTURES 2014 LLCMPM ONCOLOGY IMPACT MANAGEMENT GP LLCMPM ONCOLOGY IMPACT MANAGEMENT LPONCOLOGY IMPACT FUND (CAYMAN) LPTODD F

Document Format Files

Seq Description Document Type Size
1 SC 13D d949143dsc13d.htm SC 13D 269005
2 EX-99.C d949143dex99c.htm EX-99.C 26772
  Complete submission text file 0001193125-20-187831.txt   297802
Mailing Address C/O MPM ASSET MANAGEMENT LLC 450 KENDALL STREET CAMBRIDGE MA 02142
Business Address C/O MPM ASSET MANAGEMENT LLC 450 KENDALL STREET CAMBRIDGE MA 02142 (617) 425-9200
MPM BioVentures 2014, L.P. (Filed by) CIK: 0001609492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Subject) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91542 | Film No.: 201013553
SIC: 2834 Pharmaceutical Preparations